BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31045514)

  • 1. Long non-coding RNA polymorphisms and prediction of response to chemotherapy based on irinotecan in patients with metastatic colorectal cancer.
    Lampropoulou DI; Aravantinos G; Katifelis H; Lazaris F; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
    Cancer Biomark; 2019; 25(2):213-221. PubMed ID: 31045514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-218 and miR-100 polymorphisms as markers of irinotecan-based chemotherapy response in metastatic colorectal cancer.
    Lampropoulou DI; Aravantinos G; Laschos K; Theodosopoulos T; Papadimitriou C; Gazouli M
    Int J Colorectal Dis; 2019 Nov; 34(11):1871-1877. PubMed ID: 31598748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    Wang JZ; Xiang JJ; Wu LG; Bai YS; Chen ZW; Yin XQ; Wang Q; Guo WH; Peng Y; Guo H; Xu P
    BMC Cancer; 2017 Mar; 17(1):167. PubMed ID: 28253859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
    Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis.
    Sun F; Liang W; Qian J
    Mol Med Rep; 2019 Oct; 20(4):3583-3596. PubMed ID: 31432188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer.
    Aravantinos G; Isaakidou A; Karantanos T; Sioziou A; Theodoropoulos GE; Pektasides D; Gazouli M
    Cancer Biomark; 2015; 15(6):843-50. PubMed ID: 26406410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating
    Ntavatzikos A; Spathis A; Patapis P; Machairas N; Peros G; Konstantoudakis S; Leventakou D; Panayiotides IG; Karakitsos P; Koumarianou A
    World J Gastroenterol; 2017 Aug; 23(32):5913-5924. PubMed ID: 28932083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Long Non-Coding RNA Polymorphisms with Gastric Cancer and Atrophic Gastritis.
    Petkevicius V; Streleckiene G; Balciute K; Link A; Leja M; Malfertheiner P; Skieceviciene J; Kupcinskas J
    Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33333725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.
    Carlini LE; Meropol NJ; Bever J; Andria ML; Hill T; Gold P; Rogatko A; Wang H; Blanchard RL
    Clin Cancer Res; 2005 Feb; 11(3):1226-36. PubMed ID: 15709193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ABCC2 and SLCO1B1 Polymorphisms on Treatment Responses in Thai Metastatic Colorectal Cancer Patients Treated with Irinotecan-Based Chemotherapy.
    Treenert A; Areepium N; Tanasanvimon S
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2757-2764. PubMed ID: 30360603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association analysis of lncRNA HOTAIR genetic variants and gastric cancer risk in a Chinese population.
    Du M; Wang W; Jin H; Wang Q; Ge Y; Lu J; Ma G; Chu H; Tong N; Zhu H; Wang M; Qiang F; Zhang Z
    Oncotarget; 2015 Oct; 6(31):31255-62. PubMed ID: 26384301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of HOTAIR in lung cancer susceptibility and prognosis.
    Ren MM; Xu S; Wei YB; Yang JJ; Yang YN; Sun SS; Li YJ; Wang PY; Xie SY
    Mol Genet Genomic Med; 2020 Jul; 8(7):e1299. PubMed ID: 32394637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic oxymatrine treatment induces resistance and epithelial‑mesenchymal transition through targeting the long non-coding RNA MALAT1 in colorectal cancer cells.
    Xiong Y; Wang J; Zhu H; Liu L; Jiang Y
    Oncol Rep; 2018 Mar; 39(3):967-976. PubMed ID: 29328404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk.
    Moschovis D; Vasilaki E; Tzouvala M; Karamanolis G; Katifelis H; Legaki E; Vezakis A; Aravantinos G; Gazouli M
    Cancer Biomark; 2019; 24(1):117-123. PubMed ID: 30475759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLCO1B1 and SLC19A1 gene variants and irinotecan-induced rapid response and survival: a prospective multicenter pharmacogenetics study of metastatic colorectal cancer.
    Huang L; Zhang T; Xie C; Liao X; Yu Q; Feng J; Ma H; Dai J; Li M; Chen J; Zang A; Wang Q; Ge S; Qin K; Cai J; Yuan X
    PLoS One; 2013; 8(10):e77223. PubMed ID: 24143213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.
    Bibeau F; Lopez-Crapez E; Di Fiore F; Thezenas S; Ychou M; Blanchard F; Lamy A; Penault-Llorca F; Frébourg T; Michel P; Sabourin JC; Boissière-Michot F
    J Clin Oncol; 2009 Mar; 27(7):1122-9. PubMed ID: 19164213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA Binding Site Polymorphisms of the Long-Chain Noncoding RNA
    Yang Q; Zheng W; Shen Z; Huang G; Yang G
    Genet Test Mol Biomarkers; 2020 May; 24(5):239-248. PubMed ID: 32349546
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
    Gong WJ; Yin JY; Li XP; Fang C; Xiao D; Zhang W; Zhou HH; Li X; Liu ZQ
    Tumour Biol; 2016 Jun; 37(6):8349-58. PubMed ID: 26729200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MALAT1 polymorphism predicts MACCEs in patients with myocardial infarction.
    Zhang T; Luo JY; Liu F; Zhang XH; Luo F; Yang YN; Li XM
    BMC Cardiovasc Disord; 2022 Apr; 22(1):152. PubMed ID: 35392816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rs145204276 and rs4759314 affect the prognosis of prostate cancer by modulating the GAS5/miR-1284/HMGB1 and HOTAIR/miR-22/HMGB1 signalling pathways.
    Deng ZH; Yu GS; Pan B; Feng ZH; Huang Q; Deng JZ; Chen B; Yang SK
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):435-442. PubMed ID: 31916466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.